Prosecution Insights
Last updated: April 19, 2026

UNIVERSITY OF ZURICH

3 pending office actions

Portfolio Summary

3
Total Pending OAs
0
Final Rejections
3
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18012122 Compositions and Kits of Parts Comprising N,N-Dimethyltryptamine and Harmine and Their Use in Therapy MCKOY, QUINCY ANDRE 1626 Non-Final OA Dec 21, 2022
17569019 METHOD OF PROVIDING DISEASE-SPECIFIC BINDING MOLECULES AND TARGETS DUTT, ADITI 1675 Non-Final OA Jan 05, 2022
17610753 Ruthenium (II) Complexes and Their Use as AntiCancer Agents ELENISTE, PIERRE PAUL 1622 Non-Final OA Nov 12, 2021

Managing UNIVERSITY OF ZURICH's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month